Literature DB >> 17387309

Renal ischemia-reperfusion injury: renal dendritic cells loudly sound the alarm.

P J Nelson1.   

Abstract

Renal ischemia-reperfusion injury is a major cause of acute renal failure and kidney allograft dysfunction. Dong and colleagues now identify the surveying renal dendritic cell network as the predominant source of tumor necrosis factor-alpha during the early stages of renal ischemia-reperfusion injury, raising the possibility for direct targeting of renal dendritic cells to help ameliorate this common form of renal injury and its sequelae.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17387309     DOI： 10.1038/sj.ki.5002121

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  8 in total

1.  Depletion of macrophages and dendritic cells in ischemic acute kidney injury.

Authors:  Lawrence Lu; Sarah Faubel; Zhibin He; Ana Andres Hernando; Alkesh Jani; Ross Kedl; Charles L Edelstein
Journal:  Am J Nephrol       Date:  2012-01-25       Impact factor: 3.754

2.  The mechanisms of up-regulation of dendritic cell activity by oxidative stress.

Authors:  Ibrahim Batal; Jamil Azzi; Marwan Mounayar; Rozita Abdoli; Robert Moore; Jack Y Lee; Florencia Rosetti; Chang Wang; Paolo Fiorina; Robert Sackstein; Takaharu Ichimura; Reza Abdi
Journal:  J Leukoc Biol       Date:  2014-03-27       Impact factor: 4.962

3.  Dendritic Cells in Kidney Transplant Biopsy Samples Are Associated with T Cell Infiltration and Poor Allograft Survival.

Authors:  Ibrahim Batal; Sacha A De Serres; Kassem Safa; Vanesa Bijol; Takuya Ueno; Maristela L Onozato; A John Iafrate; Jan M Herter; Andrew H Lichtman; Tanya N Mayadas; Indira Guleria; Helmut G Rennke; Nader Najafian; Anil Chandraker
Journal:  J Am Soc Nephrol       Date:  2015-04-08       Impact factor: 10.121

4.  Sphingosine 1-Phosphate Receptor 3-Deficient Dendritic Cells Modulate Splenic Responses to Ischemia-Reperfusion Injury.

Authors:  Amandeep Bajwa; Liping Huang; Elvira Kurmaeva; Joseph C Gigliotti; Hong Ye; Jacqueline Miller; Diane L Rosin; Peter I Lobo; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2015-08-18       Impact factor: 10.121

Review 5.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

6.  Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury.

Authors:  Amandeep Bajwa; Liping Huang; Hong Ye; Krishna Dondeti; Steven Song; Diane L Rosin; Kevin R Lynch; Peter I Lobo; Li Li; Mark D Okusa
Journal:  J Immunol       Date:  2012-08-01       Impact factor: 5.422

7.  Rapamycin Alternatively Modifies Mitochondrial Dynamics in Dendritic Cells to Reduce Kidney Ischemic Reperfusion Injury.

Authors:  Maria Namwanje; Bijay Bisunke; Thomas V Rousselle; Gene G Lamanilao; Venkatadri S Sunder; Elizabeth C Patterson; Canan Kuscu; Cem Kuscu; Daniel Maluf; Manjari Kiran; Valeria Mas; James D Eason; Amandeep Bajwa
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

8.  FTY720 Regulates Mitochondria Biogenesis in Dendritic Cells to Prevent Kidney Ischemic Reperfusion Injury.

Authors:  Thomas V Rousselle; Canan Kuscu; Cem Kuscu; Kailo Schlegel; LiPing Huang; Maria Namwanje; James D Eason; Liza Makowski; Daniel Maluf; Valeria Mas; Amandeep Bajwa
Journal:  Front Immunol       Date:  2020-06-23       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.